Earnings Call for Q3FY21 Torrent Pharmaceuticals Ltd.
Conference Call with Torrent Pharmaceuticals Management and Analysts on Q3FY21 Performance and Outlook. Listen to the full earnings transcript.08-02-2021
08-02-2021
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Investor Presentation
The presentation on unaudited Consolidated Financial Results for the quarter and nine months ended 31st December, 2020 to be made to analysts is enclosed for your records.08-02-2021
TORRENT PHARMACEUTICALS LTD. - 500420 - Submission / Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, ('Listing Regulations')
We would like to inform that the Board has at its meeting held today approved, inter-alia, the following: 1) Audited Standalone Financial Results along with audit report thereon and Unaudited Consolidated Financial Results along with the limited review report of the Company for the quarter and nine months ended on 31st December, 2020. The said financial results are enclosed herewith. In terms of Regulation 47 of the Listing Regulations, the Company will publish an extract of Unaudited Consolidated Financial Results for the quarter and nine months ended on 31st December, 2020. Both Standalone and Consolidated Financial Results will be available at Company's website www.torrentpharma.com. A Press Release on Financial Results which is being submitted to the media is also enclosed herewith. 2) An interim dividend of Rs 20/- (400 %) per equity share of Rs 5/- fully paid up. The dividend is expected to be paid / dispatched on or around 25th February, 2021.08-02-2021
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Dividend Updates
We would like to inform that the Board has at its meeting held today approved an interim dividend of Rs 20/- (400 %) per equity share of Rs 5/- fully paid up. The dividend is expected to be paid / dispatched on or around 25th February, 2021.08-02-2021
TORRENT PHARMACEUTICALS LTD. - 500420 - Submission / Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015, ('Listing Regulations')
We would like to inform that the Board has at its meeting held today approved, inter-alia, the following: 1) Audited Standalone Financial Results along with audit report thereon and Unaudited Consolidated Financial Results along with the limited review report of the Company for the quarter and nine months ended on 31st December, 2020. The said financial results are enclosed herewith. In terms of Regulation 47 of the Listing Regulations, the Company will publish an extract of Unaudited Consolidated Financial Results for the quarter and nine months ended on 31st December, 2020. Both Standalone and Consolidated Financial Results will be available at Company's website www.torrentpharma.com. A Press Release on Financial Results which is being submitted to the media is also enclosed herewith. 2) An interim dividend of Rs 20/- (400 %) per equity share of Rs 5/- fully paid up. The dividend is expected to be paid / dispatched on or around 25th February, 2021.08-02-2021
TORRENT PHARMACEUTICALS LTD. - 500420 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates22-01-2021
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
We hereby inform that the Company has scheduled a teleconference with Investors / Analyst on 8th February, 2021 at 05:30 P.M. to discuss the financial performance of the Company for the quarter and nine months ended 31st December, 2020.20-01-2021
TORRENT PHARMACEUTICALS LTD. - 500420 - Fixes Record Date for Interim Dividend
Torrent Pharmaceuticals Ltd has informed BSE that the Company has fixed February 16, 2021 as the Record Date for the purpose of Payment of Interim Dividend, if declared.19-01-2021
TORRENT PHARMACEUTICALS LTD. - 500420 - Corporate Action-Board to consider Dividend
Pursuant to Regulation 42 of Listing Regulations, the Company has fixed Tuesday, 16th February, 2021 as the Record Date for taking record of the Members of the Company for the purpose of payment of Interim Dividend, if declared by the Board at their meeting scheduled to be held on Monday, 8th February, 2021.18-01-2021
TORRENT PHARMACEUTICALS LTD. - 500420 - Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
TORRENT PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/02/2021 ,inter alia, to consider and approve We would like to inform you that the meeting of the Board of Directors will be held on Monday, 08-Feb-21, inter alia, to consider and approve the Audited Financial Results on Standalone basis and Unaudited Financial Results (with limited review) on Consolidated basis of the Company for the quarter and nine months ended on 31-Dec-20. The Board would also consider payment of Interim Dividend for the year 2020-21.18-01-2021